Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

174-197 (Activation loop from InterPro)

Target domain

23-314 (Catalytic domain of the Serine/Threonine Kinase, STK10, also called Lymphocyte-Oriented Kinase or LOK)

Relief mechanism

Assay

Autoinhibited structure

Activated structure

1 structures for B7ZR30

Entry ID Method Resolution Chain Position Source
AF-B7ZR30-F1 Predicted AlphaFoldDB

No variants for B7ZR30

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for B7ZR30

No associated diseases with B7ZR30

4 regional properties for B7ZR30

Type Name Position InterPro Accession
domain Protein kinase domain 36 - 294 IPR000719
active_site Serine/threonine-protein kinase, active site 153 - 165 IPR008271
binding_site Protein kinase, ATP binding site 42 - 65 IPR017441
domain Serine/threonine-protein kinase 10, catalytic domain 23 - 314 IPR042743

Functions

Description
EC Number 2.7.11.1 Protein-serine/threonine kinases
Subcellular Localization
  • Cell membrane ; Peripheral membrane protein
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

1 GO annotations of cellular component

Name Definition
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

4 GO annotations of molecular function

Name Definition
ATP binding Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
protein homodimerization activity Binding to an identical protein to form a homodimer.
protein serine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate.
protein serine/threonine kinase activity Catalysis of the reactions: ATP + protein serine = ADP + protein serine phosphate, and ATP + protein threonine = ADP + protein threonine phosphate.

4 GO annotations of biological process

Name Definition
G2/M transition of mitotic cell cycle The mitotic cell cycle transition by which a cell in G2 commits to M phase. The process begins when the kinase activity of M cyclin/CDK complex reaches a threshold high enough for the cell cycle to proceed. This is accomplished by activating a positive feedback loop that results in the accumulation of unphosphorylated and active M cyclin/CDK complex.
oocyte maturation A developmental process, independent of morphogenetic (shape) change, that is required for an oocyte to attain its fully functional state. Oocyte maturation commences after reinitiation of meiosis commonly starting with germinal vesicle breakdown, and continues up to the second meiotic arrest prior to fertilization.
protein autophosphorylation The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
regulation of lymphocyte migration Any process that modulates the frequency, rate or extent of lymphocyte migration.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MAFANFRRIL RLPNFEKKRL REYEHVRRDV DPNQVWEIIG ELGDGAFGKV YKAKNRETGI
70 80 90 100 110 120
LAAAKVIETK NEEELEDYMV EIEILATCNH HFIVKLLGAF YWEGKLWIMI EFCPGGAVDA
130 140 150 160 170 180
VMLELDRGLK EPEIKTICRQ MLEALAYLHS MKIIHRDLKA GNVLLTLDGD IKLADFGVSA
190 200 210 220 230 240
KNVKTLQRRD SFIGTPYWMA PEVVMCETMK DAPYDYKADI WSLGITLIEM AQIEPPHHEL
250 260 270 280 290 300
NPMRVLLKIA KSEPPTLSSL SKWSPEFHSF LKTALDKNPE TRPSAAQLLE HPFVKKASGN
310 320 330 340 350 360
KPLRDLVAEA KAEVLDEIEE QGEAEEEEDS DMLSPKTKGV SQSTHVEIGK DIEREQVGNG
370 380 390 400 410 420
IKPHSATSPQ KTDSQADNYS QRRNNEVKNC PENGRPDAVN GKPDIIILNP LSSNLEPKRN
430 440 450 460 470 480
STAESYRGEE HSSASSQRQR SAQSAELVPN GSFDSPTRYF TNWSKRDSDS GSNSASESMD
490 500 510 520 530 540
ISMNLSADLS MNKETGFLSH RENRLHKKTL KRTRRFVVDG VEVSITTSKI IGDDEKKDEE
550 560 570 580 590 600
MRFLRRQELR ELRLLQKEEH RHQAQLTSKH SFQLEQMSRR FEQEMNSKRK FYDTELETLE
610 620 630 640 650 660
RHQKQQIVWM EQEHAFRRRD EAKHIKTEQE RDHIKFLEQL KLRKKELKAH VEKLPRQQRR
670 680 690 700 710 720
ETMKVQMDGF AHKKQTEEQQ FVNRQKEDLN LAMRVIVLEN RKEIYNKERE FLNKKQQLLR
730 740 750 760 770 780
DRESVIWELE ERHLQERHQL VKQQLKDQYF LQRHELLRKH EKEQEQMQRY NQRMMEQLRL
790 800 810 820 830 840
RQQQEKVRLP KNQKAEAKTR MTMFKKSLHI SPSGSAAEQR DKIKQFSLQE EKRQKAERLQ
850 860 870 880 890 900
QQQKHEHQLM EMLAECDCNV RDLLQMQNEK CHLLVEHETQ KLKSLDEHHI QLIREWRENI
910 920 930 940
RPRKKAFEDE LELKKEAQEM FFRLNEEVAG DPFLSNKPTR FYSFSSPEAS